• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白藜芦醇治疗射血分数降低的心力衰竭患者的血液流变学改变。

Hemorheological Alterations in Patients with Heart Failure with Reduced Ejection Fraction Treated by Resveratrol.

机构信息

Division of Cardiology, 1st Department of Medicine, Medical School, University of Pécs, Hungary.

Szentágothai Research Centre, University of Pécs, Hungary.

出版信息

Cardiovasc Ther. 2020 Jun 30;2020:7262474. doi: 10.1155/2020/7262474. eCollection 2020.

DOI:10.1155/2020/7262474
PMID:32695229
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7350166/
Abstract

OBJECTIVES

Several beneficial effects of resveratrol have already been published. This study evaluated the effect of resveratrol on the hemorheological parameters in patients with heart failure with reduced ejection fraction.

METHODS

In our double-blind, placebo-controlled human clinical trial, we enrolled 60 outpatients with heart failure. Patients were randomized into two groups: receiving either 100 mg resveratrol capsule daily or placebo for 3 months. Hematocrit was determined by microhematocrit centrifuge. Plasma and whole blood viscosity was evaluated by capillary viscometer. Erythrocyte aggregation was measured by both LORCA and Myrenne aggregometers. LORCA ektacytometer was used for measuring erythrocyte deformability. Exercise capacity was assessed by a 6-minute walk test.

RESULTS

Resveratrol treatment did not have any significant effect on hematocrit and viscosity. The erythrocyte deformability also remained unchanged. However, significant improvement of red blood cell aggregation was observed in the resveratrol group compared to baseline after 3 months. Furthermore, positive correlation was found between the exercise capacity and the hemorheological properties (Hct, WBV, and RBC aggregation and deformability) as well.

CONCLUSION

These findings indicate that resveratrol can significantly reduce red blood cell aggregation, which may positively influence microcirculation, which may contribute to the improvement of tissue perfusion and oxygen supply in heart failure.

摘要

目的

白藜芦醇已经具有多种有益的作用。本研究评估了白藜芦醇对射血分数降低的心力衰竭患者血液流变学参数的影响。

方法

在我们的这项双盲、安慰剂对照的人体临床试验中,共纳入了 60 名心力衰竭的门诊患者。患者被随机分为两组:每天服用 100 毫克白藜芦醇胶囊或安慰剂,持续 3 个月。通过微量血液离心机确定血细胞比容。通过毛细管粘度计评估血浆和全血粘度。使用 LORCA 和 Myrenne 聚集仪测量红细胞聚集。使用 LORCA 细胞电泳仪测量红细胞变形性。通过 6 分钟步行试验评估运动能力。

结果

白藜芦醇治疗对血细胞比容和粘度没有任何显著影响。红细胞变形性也保持不变。然而,与基线相比,白藜芦醇组在 3 个月后红细胞聚集显著改善。此外,运动能力与血液流变学特性(Hct、WBV、RBC 聚集和变形性)之间存在正相关。

结论

这些发现表明,白藜芦醇可以显著降低红细胞聚集,这可能会对微循环产生积极影响,从而有助于改善心力衰竭患者的组织灌注和氧气供应。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b20a/7350166/00820780dbd0/CDTP2020-7262474.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b20a/7350166/d70fc442db29/CDTP2020-7262474.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b20a/7350166/00820780dbd0/CDTP2020-7262474.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b20a/7350166/d70fc442db29/CDTP2020-7262474.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b20a/7350166/00820780dbd0/CDTP2020-7262474.002.jpg

相似文献

1
Hemorheological Alterations in Patients with Heart Failure with Reduced Ejection Fraction Treated by Resveratrol.白藜芦醇治疗射血分数降低的心力衰竭患者的血液流变学改变。
Cardiovasc Ther. 2020 Jun 30;2020:7262474. doi: 10.1155/2020/7262474. eCollection 2020.
2
Moderate red wine consumption improves hemorheological parameters in healthy volunteers.适量饮用红酒可改善健康志愿者的血液流变学参数。
Clin Hemorheol Microcirc. 2014;56(1):13-23. doi: 10.3233/CH-2012-1640.
3
Testosterone Replacement Therapy in Deficient Patients With Chronic Heart Failure: A Randomized Double-Blind Controlled Pilot Study.慢性心力衰竭患者睾酮替代治疗:一项随机双盲对照试验性研究
J Cardiovasc Pharmacol Ther. 2018 Nov;23(6):543-550. doi: 10.1177/1074248418784020. Epub 2018 Jun 21.
4
Clinical assessment of complementary treatment with Qishen Yiqi dripping pills on ischemic heart failure: study protocol for a randomized, double-blind, multicenter, placebo-controlled trial (CACT-IHF).芪参益气滴丸对缺血性心力衰竭的补充治疗的临床评估:一项随机、双盲、多中心、安慰剂对照试验的研究方案(CACT-IHF)。
Trials. 2013 May 14;14:138. doi: 10.1186/1745-6215-14-138.
5
Safety and efficacy of Qishen granules in patients with chronic heart failure: study protocol for a randomized controlled trial.芪参颗粒治疗慢性心力衰竭患者的安全性和有效性:一项随机对照试验的研究方案
Trials. 2017 Oct 10;18(1):468. doi: 10.1186/s13063-017-2193-z.
6
Efficacy and Safety of Inorganic Nitrate Versus Placebo Treatment in Heart Failure with Preserved Ejection Fraction.无机硝酸盐与安慰剂治疗射血分数保留心力衰竭的疗效和安全性。
Cardiovasc Drugs Ther. 2020 Aug;34(4):503-513. doi: 10.1007/s10557-020-06980-4.
7
Efficacy of coenzyme Q10 in patients with cardiac failure: a meta-analysis of clinical trials.辅酶Q10对心力衰竭患者的疗效:一项临床试验的荟萃分析。
BMC Cardiovasc Disord. 2017 Jul 24;17(1):196. doi: 10.1186/s12872-017-0628-9.
8
I(f) current inhibitor ivabradine in patients with idiopathic dilated cardiomyopathy: Impact on the exercise tolerance and quality of life.I(f) 伊伐布雷定对特发性扩张型心肌病患者的影响:对运动耐量和生活质量的影响 。 你提供的原文可能存在一些错误或不完整的地方,正确的可能是:Impact of the current inhibitor ivabradine in patients with idiopathic dilated cardiomyopathy: on the exercise tolerance and quality of life. 即“当前抑制剂伊伐布雷定对特发性扩张型心肌病患者的影响:对运动耐量和生活质量的影响” 。
Cardiol J. 2015;22(2):227-32. doi: 10.5603/CJ.a2014.0057. Epub 2014 Sep 2.
9
Extended-Release Oral Milrinone for the Treatment of Heart Failure With Preserved Ejection Fraction.延长释放型口服米力农治疗射血分数保留的心力衰竭。
J Am Heart Assoc. 2020 Jul 7;9(13):e015026. doi: 10.1161/JAHA.119.015026. Epub 2020 Jun 18.
10
Ivabradine Improves Cardiac Function and Increases Exercise Capacity in Patients with Chronic Heart Failure.伊伐布雷定可改善慢性心力衰竭患者的心功能并提高运动能力。
Int Heart J. 2019 Jul 27;60(4):899-909. doi: 10.1536/ihj.18-559. Epub 2019 Jul 12.

引用本文的文献

1
Resveratrol improves lipid profile and recovers heart function in postoperative CABG patients.白藜芦醇可改善冠状动脉旁路移植术(CABG)术后患者的血脂水平并恢复心脏功能。
Mol Cell Biochem. 2025 Jul 17. doi: 10.1007/s11010-025-05351-7.
2
Impact of probiotics and polyphenols on adults with heart failure: a systematic review and meta-analysis.益生菌和多酚对心力衰竭成人患者的影响:一项系统评价和荟萃分析。
Eur J Med Res. 2025 Apr 21;30(1):313. doi: 10.1186/s40001-025-02538-y.
3
Traditional Chinese medicine compounds modulate signaling pathways to improve cardiac-related pathology.

本文引用的文献

1
Effect of Resveratrol on Blood Rheological Properties in LPS-Challenged Rats.白藜芦醇对脂多糖攻击大鼠血液流变学特性的影响。
Front Physiol. 2018 Aug 29;9:1202. doi: 10.3389/fphys.2018.01202. eCollection 2018.
2
Lower limb ischemia and microrheological alterations in patients with diabetic retinopathy.糖尿病视网膜病变患者的下肢缺血和微观流变学改变
Clin Hemorheol Microcirc. 2018;69(1-2):23-35. doi: 10.3233/CH-189103.
3
Effect of resveratrol on platelet aggregation by fibrinogen protection.白藜芦醇通过保护纤维蛋白原对血小板聚集的影响。
中药复方通过调节信号通路改善心脏相关病理状况。
Front Pharmacol. 2025 Apr 2;16:1499060. doi: 10.3389/fphar.2025.1499060. eCollection 2025.
4
Back to the Basics of SARS-CoV-2 Biochemistry: Microvascular Occlusive Glycan Bindings Govern Its Morbidities and Inform Therapeutic Responses.回归SARS-CoV-2生物化学的基础:微血管闭塞性聚糖结合决定其发病机制并为治疗反应提供依据。
Viruses. 2024 Apr 22;16(4):647. doi: 10.3390/v16040647.
5
Enhancing the Bioavailability of Resveratrol: Combine It, Derivatize It, or Encapsulate It?提高白藜芦醇的生物利用度:联合使用、衍生化还是包封?
Pharmaceutics. 2024 Apr 22;16(4):569. doi: 10.3390/pharmaceutics16040569.
6
Resveratrol for the Management of Human Health: How Far Have We Come? A Systematic Review of Resveratrol Clinical Trials to Highlight Gaps and Opportunities.白藜芦醇在人类健康管理中的应用:我们已经走了多远?系统综述白藜芦醇临床试验,以突显差距和机遇。
Int J Mol Sci. 2024 Jan 6;25(2):747. doi: 10.3390/ijms25020747.
7
Resveratrol and beyond: The Effect of Natural Polyphenols on the Cardiovascular System: A Narrative Review.白藜芦醇及其他:天然多酚对心血管系统的影响:一篇叙述性综述。
Biomedicines. 2023 Oct 25;11(11):2888. doi: 10.3390/biomedicines11112888.
8
Impact of polyphenols on heart failure and cardiac hypertrophy: clinical effects and molecular mechanisms.多酚对心力衰竭和心肌肥大的影响:临床效应与分子机制
Front Cardiovasc Med. 2023 May 24;10:1174816. doi: 10.3389/fcvm.2023.1174816. eCollection 2023.
9
Synergistic Beneficial Effects of Resveratrol and Diet on High-Fat Diet-Induced Obesity.白藜芦醇与饮食协同对高脂肪饮食诱导肥胖的有益作用。
Medicina (Kaunas). 2022 Sep 18;58(9):1301. doi: 10.3390/medicina58091301.
10
Role of resveratrol in inhibiting pathological cardiac remodeling.白藜芦醇在抑制病理性心脏重塑中的作用。
Front Pharmacol. 2022 Sep 1;13:924473. doi: 10.3389/fphar.2022.924473. eCollection 2022.
Biophys Chem. 2017 Mar;222:41-48. doi: 10.1016/j.bpc.2016.12.004. Epub 2017 Jan 2.
4
Microcirculation and blood rheology abnormalities in chronic heart failure.慢性心力衰竭中的微循环与血液流变学异常
Clin Hemorheol Microcirc. 2017;65(4):383-391. doi: 10.3233/CH-16206.
5
Erythrocyte oxidative stress is associated with cell deformability in patients with retinal vein occlusion.红细胞氧化应激与视网膜静脉阻塞患者的细胞变形能力有关。
J Thromb Haemost. 2016 Nov;14(11):2287-2297. doi: 10.1111/jth.13482. Epub 2016 Oct 11.
6
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.2016欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南:欧洲心脏病学会(ESC)急性和慢性心力衰竭诊断与治疗工作组编写,欧洲心脏病学会心力衰竭协会(HFA)提供特别贡献。
Eur Heart J. 2016 Jul 14;37(27):2129-2200. doi: 10.1093/eurheartj/ehw128. Epub 2016 May 20.
7
Pathophysiology of Heart Failure.心力衰竭的病理生理学
Compr Physiol. 2015 Dec 15;6(1):187-214. doi: 10.1002/cphy.c140055.
8
Therapeutic potential of resveratrol in heart failure.白藜芦醇在心力衰竭中的治疗潜力。
Ann N Y Acad Sci. 2015 Aug;1348(1):32-45. doi: 10.1111/nyas.12839. Epub 2015 Jul 23.
9
Association of altered hemorheology with oxidative stress and inflammation in metabolic syndrome.代谢综合征中血液流变学改变与氧化应激和炎症的关联。
Redox Rep. 2015 May;20(3):139-44. doi: 10.1179/1351000214Y.0000000120. Epub 2014 Dec 12.
10
Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases.白藜芦醇在心血管疾病治疗中作用的临床前及临床证据。
Biochim Biophys Acta. 2015 Jun;1852(6):1155-77. doi: 10.1016/j.bbadis.2014.10.016. Epub 2014 Nov 1.